ArticleJournal of experimental & clinical cancer research : CR2022

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer.

Zhang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.